Studies conducted on animal subjects specifically looked at the following areas of the GI tract: Intestines Liver Stomach Esophagus Duodenum The findings from this study only further proved to support the original findings of past research
Patients with a history of severe gastrointestinal disease, particularly those with inflammatory bowel disease, severe gastroesophageal reflux disease, or history of pancreatitis, require careful evaluation before considering this therapy
Patients seeking physician-guided medical weight loss may discuss all available treatment options during consultation to determine the most appropriate path forward
Common side effects can include nausea, vomiting, diarrhea, constipation, stomach discomfort, bloating, and decreased appetite
Discuss this dynamic with your provider to ensure your treatment plan is aligned
Report any suspected side effects to the MHRA through the Yellow Card scheme (yellowcard